| View |
|
DRP-15009
|
Cetrorelix (as acetate)
|
Cetrostal
|
250 mcg/500mcL
|
Solution for Injection (SC)
|
Anti-Gonadotropin-Releasing Hormone
|
Memphis Vision Care Pvt. Ltd.
|
India
|
Initial
|
12 March 2024
|
11 March 2029
|
| View |
|
DRP-14971
|
Amoxicillin (as trihydrate)
|
Ambimox
|
500 mg
|
Capsule
|
Antibacterial
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
29 February 2024
|
01 March 2029
|
| View |
|
DRP-9393
|
Multivitamins + Iron
|
None
|
Each capsule contains: Iron (equivalent to 200 mg Ferrous Sulfate)-65 mg Pyridoxine HCI (Vitamin B6)-2.44mg Ascorbic Acid (Vitamin C)-120mg Riboflavin (Vitamin B2)-2.40mg Niacinamide (Vitamin B3)-20mg Folic Acid-440 mcg Thiamine HCI (Vitamin B1)-2.68mg Cyanocobalamin (Vitamin B12)-12mcg
|
Capsule
|
Vitamins / Mineral
|
Vonwelt, Inc.
|
|
Automatic Renewal (OTC)
|
27 April 2021
|
02 July 2026
|
| View |
|
DR-XY49019
|
Rivaroxaban
|
Rivaxored
|
10 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Dr. Reddy's Laboratories Limited (FTO Unit 2)
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DR-XY49020
|
Rivaroxaban
|
Rivaxored
|
15 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Dr. Reddy's Laboratories Limited (FTO - Unit 2)
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DR-XY49021
|
Rivaroxaban
|
Rivaxored
|
20 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Dr. Reddy's Laboratories Limited (FTO - Unit 2)
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15011
|
Metfromin Hydrochloride
|
None
|
500 mg
|
Extended-Released Tablet
|
Oral Hypoglycemic Agent
|
Bafna Pharmaceuticals Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2026
|
| View |
|
DRP-15021
|
Sodium Alginate Sodium Bicarbonate + Calcium
Carbonate
|
Tumiwel
|
500mg/213mg/ 325mg per 10 mL
|
Oral Suspension
|
Antacid
|
LifeSquare Laboratories Inc.
|
Philippines
|
Initial [OTC]
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15023
|
Lamotrigine
|
Lymogin
|
25 mg
|
Tablet
|
Antiepileptic
|
Globela Pharma Private Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15024
|
Lamotrigine
|
Lymogin
|
50 mg
|
Tablet
|
Antiepileptic
|
Globela Pharma Private Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15025
|
Lamotrigine
|
Lymogin
|
100 mg
|
Tablet
|
Antiepileptic
|
Globela Pharma Private Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
HRP-643
|
Povidone-Iodine
|
Poviline 10
|
100 mg/mL (10% w/v)
|
Topical Solution
|
Antiseptic/Disinfectant
|
Nanz Med Science Pharma Pvt. Ltd.
|
India
|
Initial [HR]
|
13 March 2024
|
13 March 2029
|
| View |
|
HRP-642
|
Povidone-Iodine
|
Poviline 7.5
|
75 mg/mL (7.5% w/v)
|
Topical Solution
|
Antiseptic/Disinfectant
|
Nanz Med Science Pharma Pvt. Ltd.
|
India
|
Initial [HR]
|
13 March 2024
|
13 March 2029
|
| View |
|
DRHR-2351
|
Benzalkonium Chloride
|
Ultrasept
|
0.2% w/v
|
Solution
|
Antiseptic/Disinfectant
|
J. Chemie Laboratories, Inc.
|
Philippines
|
Initial [HR]
|
13 March 2024
|
13 March 2026
|
| View |
|
DR- XY49022
|
Sevoflurane
|
Sevotroy 250
|
100% v/v Volatile
|
Liquid for Inhalation.
|
General Anesthetic
|
Troikaa Pharmaceuticals, Ltd.
|
India
|
Initial
|
14 March 2024
|
14 March 2029
|
| View |
|
DRP-15031
|
Benzylpenicillin (as sodium)
|
Inzocillin-5
|
5,000,000 IU (equivalent to 3 g)
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Beta-lactamase Sensitive Penicillin)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
Initial
|
20 March 2024
|
20 March 2029
|
| View |
|
DRP-15026
|
Vecuronium bromide
|
Sacuron 4
|
4 mg
|
Lyophilized Powder for Injection (IV)
|
Muscle relaxant
|
Sakar Healthcare Limited
|
India
|
Initial
|
18 March 2024
|
18 March 2029
|
| View |
|
DRP-1552-03
|
FURAZOLIDONE
|
Unbranded
|
50 mg/15 mL
|
Suspension
|
Antiprotozoal
|
Lifesquare Laboratories Inc.
|
Philippines
|
Renewal
|
28 May 2024
|
19 June 2026
|
| View |
|
DRP-15027
|
Fluticasone
|
Ticanase
|
50 mcg/actuation (0.05% w/w)
|
Nasal Spray
|
Corticosteroids.
|
European Egyptian Pharmaceutical Industries Co.
|
Egypt
|
Initial
|
19 March 2024
|
19 March 2029
|
| View |
|
DRP-15032
|
Bupivacaine hydrochloride
|
Bupidex
|
5 mg/mL (0.5% w/v)
|
Solution for Intrathecal Injection
|
Local Anesthetic (Amide)
|
Swiss Parenterals Ltd. (Block-B)
|
India
|
Initial
|
20 March 2024
|
20 March 2029
|